plays a key role in the progression of AML and MLL leukemia, and fusion proteins generated by chromosomal rearrangements in MLL can induce increased expression of Meis1 (55, 61, 63) . The Meis relative, Prep1, plays a role in hematopoietic stem cell function, and in early T cell development (12, 50, 51) . Pbx proteins, which are common partners of Meis family members, have also been implicated in tumorigenesis. The Pbx1 gene is fused to the transcription factor E2A as a result of the t(1;19) translocation in pre-B cell leukemia (25, 26) . This fusion prevents interaction with Meis proteins and converts Pbx1 to a transcriptional activator. Thus, there is significant evidence for deregulation of Meis and Pbx family proteins promoting tumorigenesis in lymphoid and hematopoietic cells.
Sp1 is a zinc finger containing transcription factor which regulates a large number of genes via binding to a GC-rich consensus site (6, 13, 24) . The related Sp3 protein binds to the same sequence, and is highly homologous over the carboxylterminal zinc finger domain, but is less well conserved outside this region (27) . Sp1 has been shown to regulate the p15 promoter, and to activate p15 cooperatively with TGFβ-regulated Smads (32, 33) . Sp1 and Sp3 belong to a larger family of Kruppel related zinc finger transcription factors that includes more than 15 KLF (for Kruppel-like factor) proteins (23, 60) . The KLF family includes GKLF (gut enriched KLF), also known as Klf4, which although highly expressed in gut epithelium is also expressed in a wide variety of other tissues (14) , and plays a role in the maintenance of pluripotent stem cells (36, 47, 62) . Klf4 has the characteristic three zinc fingers of the KLF family located at its carboxyl-terminus, and contains both a transcriptional repression domain and an activation domain that can interact with p300/CBP (19, 66) . Thus Klf4 can activate or repress transcription, possibly depending on the context. Klf4 also plays apparently contradictory roles in tumorigenesis as there is evidence for Klf4 being both a tumor suppressor and an oncogene (14, 38) . For example, Klf4 levels are decreased in colorectal cancer and in medulloblastoma, both by hyper-methylation and mutation (45, 68) . In contrast, Klf4 expression in keratinocytes can induce squamous epithelial dysplasia (16) . Consistent with a role as an oncogene, Klf4 expression is increased in a number of cancers, including mammary carcinomas and some squamous cell cancers (38).
Here we show that Klf4 can recruit Meis2 and Pbx1 to a sub-optimal Meis/Pbx site adjacent to a GC-box in the p15 promoter. The GC-box is essential for Meis2 and 
Materials and Methods

Plasmids and oligonucleotides
TGIF expression and shRNA plasmids have been described previously (1) . p15 reporter constructs were created in pGL2 or pGL3 (Promega) or in pGL2 basic into which a minimal TATA element from the Adenovirus MLP had been inserted. The E-cad-luc reporter contains sequences from 178bp upstream of the transcriptional start to +92 from the mouse gene. The four copy SBR2 and two copy Meis/Pbx reporters are as described (21, 56) . Meis2, Pbx1, KLF and Sp1 expression constructs were created in a modified pCMV5 with either a Flag or T7 epitope tag. KLF4 was also expressed from within pCDNA3. Meis2 and Pbx1 mutants and deletion constructs are as described (21) . Pax3
and Etv1 luciferase reporters are as described (8, 11) . Table 1 for siRNA sequences. RNA was isolated 60 hours after transfection. The control pool (mouse siGENOME Non-targeting siRNA pool #3) was used for the non-targeting control. For EdU labeling, cells were labeled with 10µM EdU for 1 hour at 37°C, and after fixation in 4% paraformaldehyde, were permeabilized with Triton X-100 for 30 minutes at room temperature. EdU was detected with an AlexaFluor 488 EdU detection kit (Click-iT EdU, Molecular Probes), according to the manufacturer's protocol, and DNA was stained with Hoechst 33342. Images were captured on a Zeiss AxioObserver with Volocity.
Cell culture and siRNA knock-down
RNA analysis
RNA was isolated and purified using Absolutely RNA kit (Stratagene). For qRT-PCR, cDNA was generated using Superscript III (Invitrogen), and analyzed in triplicate by real time PCR using a BioRad MyIQ cycler and Sensimix Plus SYBRgreen plus FITC mix (Quantace). Intron spanning primer pairs were selected using Primer3 (http://frodo.wi.mit.edu/). See Supplemental Table 1 for primer sequences. Expression was normalized to cyclophilin using the ∆∆Ct method, and is shown as mean plus standard deviation of triplicate experiments.
Immunoprecipitation and western blotting
COS1 cells were transfected using LipofectAmine (Invitrogen). 40 h after transfection, cells were lysed by sonication in PBS with 1% NP40, 1mM DTT and protease inhibitors.
Immunocomplexes were precipitated with Flag M2-agarose (Sigma). Following SDSpolyacrylamide gel electrophoresis, proteins were electroblotted to Immobilon-P (Millipore) and incubated with antisera specific for Flag (Sigma) or T7 (Novagen).
Proteins were visualized with horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit Ig (Pierce) and ECL (Amersham Pharmacia Biotech). For testing dependence on DNA binding, ethidium bromide was added to a concentration of 1µM to cell lysates prior to precipitation.
DNA affinity precipitation
For isolation of protein complexes on double stranded DNA oligonucleotides, lysates were prepared from 75% of a confluent 15cm dish of COS1 cells for each condition, in MSLD (100mM NaCl, 20mM HEPES, pH 7.8, 10% glycerol, 0.1% Tween-20, with 1mM DTT and protease inhibitors. Lysates were pre-cleared with protein A agarose (Pierce) and incubated in 1ml with 100ng of biotinylated double stranded oligonucleotide and 1µg poly(dI-dC).poly(dI-dC). Complexes were isolated on streptavidin-agarose, and washed 4 times in binding buffer, then subjected to analysis by SDS-PAGE and western blotting. Sp1 antibody is from Upstate (#07-645), Meis2 is from Abnova (H00004212-M01) and Pbx1 is from Abnova (H00005087-M01).
Luciferase assays
HepG2 cells were transfected using Exgen 500 (MBI Fermentas) according to the manufacturer's instructions. Cells were transfected with firefly luciferase reporters, a Renilla transfection control (phCMVRLuc; Promega), and the indicated expression constructs. After 40 hours firefly luciferase activity was assayed using firefly substrate (Biotium) and Renilla luciferase was assayed with 0.09µM coelenterazine (Biosynth), using a Berthold LB953 luminometer. Mithramycin was added to a final concentration of 200nM, 24 hours prior to analysis, where indicated. 
In silico site search
Mouse and human genomic databases were searched using the Site Search program (59): http://www.sitesearch.mshri.on.ca/Genome/index.html. We searched 2kb upstream of the predicted start site of each gene, for the combination of a Klf4 site (RRGGYSY; (58)) with both Meis and Pbx consensus sites (TGACA and CAATC) within 40bp either side of the Klf4 site. This combination had to be present in both mouse and human, and we then accepted only those in which the orientation was the same in both mouse and on July 7, 2017 by guest http://mcb.asm.org/ Downloaded from human. We then ranked the hits by the total difference in spacing between the sites between mouse and human.
Activation of the p15 promoter by Meis2d and Pbx1a
As shown in Figure 1A , the proximal 1kb of the human p15 promoter contains four close matches to the Meis/Tgif consensus binding site. One of these (a 6/7 match) is present within the SBR2 that contributes to p15 expression in response to TGFβ signaling (56) .
We were, therefore, interested to know whether the p15 gene is a target for direct activation by Meis2 and repression by Tgif1, as has been proposed for the dopamine 1A receptor gene (65) . In the context of the 1kb p15 reporter construct, we observed little effect of Tgif1 over-expression or knock-down in these cells (data not shown). TALE homeodomains, including members of the Meis and Prep family often bind to DNA together with other homeodomain proteins, including Hox and Pbx proteins. We, therefore, tested whether any response of the p15 promoter to Meis2d might be affected by Pbx1a. Coexpression of Meis2d with a reporter in which luciferase activity is driven by 1kb fragment of the p15 promoter resulted in around 3.5-fold activation and coexpression of Pbx1a increased p15 activity to around 16 fold ( Figure 1A) . We next analyzed a series of p15 promoter deletions to identify the region that responds to Meis2 and Pbx1 (see Supplemental Figure 1A ). As shown in Figure 1A We next compared the effects of expression of Meis2d and Pbx1a on transcriptional reporters containing promoter regions from the p15 gene (two Sp1 sites), p21 (four Sp1 sites), TK (one Sp1 site) and E-cadherin (one Sp1 site). As shown in Figure 1B , the TK-luc and p21-luc reporters did not respond to Meis2d and Pbx1a, whereas the E-cadherin reporter was activated around 7-fold with both Meis2d and Pbx1a. We repeated these assays in the human SK-HEP-1 cell line, which was derived from a patient with adenocarcinoma, and again observed activation of the p15 and Ecadherin reporters by Meis2d and Pbx1a (Supplemental Figure 1E ). For the E-cadherin reporter, expression of either Meis2 or Pbx alone activates less than 2 fold, but expression of both results in around 15 fold activation. This data suggests that Meis2 and Pbx1 may activate expression of a subset of Sp1 site containing promoters.
Regulation of p15 expression and cell cycle progression and Meis/Pbx
To test whether the regulation of p15 and E-cadherin genes by Meis2d and Pbx1a occurred at the endogenous level, we knocked down Meis2 and Pbx1 and analyzed gene expression by qRT-PCR. HepG2 cells were transfected with siRNA oligonucleotides: a non-specific pool as control or siRNAs to Meis2, Pbx1 or both.
Targeting Meis2 resulted in around 60% reduction in Meis2 mRNA levels, and Pbx1 knock-down decreased its expression by up to 75% ( Figure 1C ). Analysis of p15 expression revealed a significant decrease when Meis2 or Pbx1 was knocked down, and a similar effect of the double Meis2/Pbx1 knockdown. We also observed a significant decrease in E-cadherin expression with knock-down of either Meis2 or Pbx1, or with knock-down of both together ( Figure 1C ). We next analyzed expression of p21 and several other cell cycle regulators in cells with Meis2 and Pbx1 knock-down. p21 expression was significantly reduced in the knock-down, but only by about 40%. In contrast, we observed little effect on expression of other cell cycle regulators, although expression of Cyclin A2 was somewhat increased ( Figure 1D ). Since we observed decreased expression of p15, as well as some reduction in p21 expression, we next tested whether this affected cell cycle progression. Following knock-down of Meis2, Pbx1, or both together, cells were incubated with EdU to identify those that were undergoing DNA synthesis. As shown in Figure 1E , there was a significant increase in the proportion of EdU positive cells when either Meis2 or Pbx1 was knocked down, consistent with the idea that these cells were more rapidly transiting G1 and entering S phase. Together, these results suggest that Meis2 and Pbx1 can contribute to the activation of the p15 and E-cadherin genes in HepG2 cells, and that reducing Meis2 and Pbx1 levels promotes proliferation.
The Meis2 activation domain is required for activation of p15
To test the requirements for activation of p15 and E-cadherin expression by Meis2d and Pbx1a, we tested a panel of Meis2d and Pbx1a mutants in HepG2 cells ( Figure 2A ). We tested two truncation mutants of Meis2d, which affect either Pbx1 interaction or remove the transcriptional activation domain, and a mutant in which one of the DNA contact residues is altered from arginine to methionine (R332M) (21) . We also tested a DNA binding point mutant form of Pbx1a (N286S), and a deletion mutant that has reduced interaction with Meis2d. We first verified the effects of these mutations on the activity of 
GC boxes contribute to Meis/Pbx activation of the p15 and E-cadherin promoters
To test whether activation by Meis2d and Pbx1a required the Sp1 sites in the p15 promoter, we analyzed the activity of the -967/+78 and -113/+78 reporters in HepG2 cells treated with mithramycin, which is used as a relatively broad specificity inhibitor of transcription factor binding to GC-rich elements, such as Sp1 sites. As shown in Figure   3A , the activation of both p15 reporters by Meis2d and Pbx1a was significantly reduced in cells treated with mithramycin. As with the p15 reporter constructs, we observed a reduction in the activation of the E-cadherin reporter by Meis2d/Pbx1a in the presence of mithramycin ( Figure 3A) . In contrast, the consensus Pbx/Meis site reporter, which is not GC-rich and is bound directly by Pbx1a and Meis2d was unaffected by mithramycin treatment. To test whether the Sp1 sites in the p15 promoter could contribute to recruitment of Meis2, we used a series of biotinylated DNA duplexes to isolate the endogenous Sp1 and Meis2 proteins from COS1 cells. We focused on the region of the p15 promoter which contains the 5' most Sp1 site and the sequences with partial matches to Meis and Pbx sites (see Figure 3D for oligonucleotide sequences). As shown in Figure 3B , both Sp1 and Meis2 bound specifically to the p15 wild type oligonucleotide, but not to the unrelated DR5 retinoic acid response element. Similar results were seen with the binding of endogenous Pbx1 to this element. Importantly, mutation of the Sp1 site (GC mutant) abolished binding of Sp1 as well as Meis2 and Pbx1 to the p15 sequence ( Figure 3B ). To further delineate the requirements for recruitment of Meis2 to this site we tested three other mutant forms of this element, in which the closest matches to Pbx and Meis consensus binding sites had been mutated. Sp1 clearly bound to all of the p15 elements tested except for the GC mutant ( Figure 3C ). In contrast, we observed greatly reduced binding of Meis2 when either the Sp1 site or the Sp1-proximal Meis-like site was mutated (GC and M1 mutants, Figure 3C ). Mutation of a second Meis-like site had no effect on Meis2 binding, whereas mutating the closest match to a Pbx consensus abolished recruitment of Meis2 (p15mut P1). Together, these data suggest that endogenously expressed Meis2 and Pbx1 can form a complex on DNA at a sub-optimal site, dependent on the adjacent GC-rich sequence.
We next wanted to test whether Meis2 and Pbx1 were present at the endogenous p15 locus. We expressed Flag-epitope tagged versions of each protein and performed ChIP with anti-Flag agarose. We analyzed three regions of the p15 locus ( Figure 3E ), including the proximal promoter region, centered around 56bp upstream of the transcriptional start site, a second region further upstream (at -1265bp from the start) and a region 9kb 3' of the start. As shown in Figure 3F , Meis2d was found at the p15 proximal promoter, but was not significantly enriched either at sequences further upstream or at a far downstream region. In contrast, Meis2e, which lacks the homeodomain was not enriched at the p15 promoter. We next performed similar experiments with low levels of transfected Flag-Meis2d, with or without coexpression of T7-tagged Pbx1a. As shown in Figure 3G , coexpression of Pbx1a increased recruitment of Meis2d to the p15 promoter, consistent with the formation of a co-complex on DNA.
Together, these data suggest that Meis2d and Pbx1a can be recruited to the proximal p15 promoter, dependent on the presence of a Sp1 binding site.
Pbx1a interacts with Klf4
Since the Sp1 sites in the p15 promoter appeared to be critical for the transcriptional response to Meis2d and Pbx1a and for their binding to DNA, we wondered whether Meis2d or Pbx1a might interact with Sp1. COS1 cells were transfected with expression constructs encoding T7 epitope-tagged Sp1 or Sp3, together with Flag-tagged Meis2d, Meis2e or Pbx1a. Protein complexes were collected on anti-Flag agarose and analyzed for the presence of co-precipitating T7-Sp1 or T7-Sp3. Meis2d coprecipitated with both Sp1 and Sp3, whereas the Meis2e splice variant did not (Supplemental Figure 2A) .
Additionally, we observed some interaction with Pbx1a. To identify the region of Meis2 responsible for interaction with Sp1, we tested a deletion mutant (2-345) lacking the on July 7, 2017 by guest http://mcb.asm.org/
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Meis2d transcriptional activation domain, and Meis2d(R332M) that is unable to bind DNA. Amino acids 2-345 of Meis2 were still able to interact with Sp1 in this assay, whereas the R332M point mutation completely abolished interaction with Sp1, raising the possibility that Meis2d-Sp1 interaction is dependent on DNA binding (Supplemental Figure 2B) . To test whether the interaction of Meis2 with Sp1 was dependent on DNA binding, we performed coimmunoprecipitation experiments and incubated lysates with ethidium bromide prior to precipitation with anti-Flag agarose. The inclusion of ethidium bromide effectively reduced the Meis2d-Sp1 interaction (Supplemental Figure 2C) . Thus the apparent interaction of Meis2d with Sp1 is mediated by binding to DNA.
Since the GC-rich Sp1 sites in the p15 promoter contribute to the Meis2d/Pbx1a response and to binding to DNA, we tested whether other members of the SP/KLF family could interact with Meis2d or Pbx1a. We first tested for effects of Klf4 on p15 expression and interaction with Meis2d and Pbx1a. As shown in Figure 4A , we observed interaction of both Meis2d and Pbx1a with Klf4, although the interaction was more readily detectable with Pbx1a. Importantly, this interaction was not affected by inclusion of ethidium bromide. The interaction was not affected by the introduction of a DNA binding point mutation (N286S) into Pbx1a, further suggesting that it was not entirely dependent on DNA binding ( Figure 4B ). Additionally, comparison of the interaction between Meis2d and Sp1 or Klf4 revealed that the Klf4 interaction was much more readily detectable (Supplemental Figure 2D) . We also tested interaction with Klf3 and Klf5, but did not detect a clear interaction with either Meis2d or Pbx1a ( Figure 4B and Supplemental Figure 2D ). As shown in Figure 4C , deletion of the Pbx1a homeodomain (construct 2-233) had little effect on interaction with Klf4, whereas removal of the amino-terminal 90 amino acids clearly reduced the interaction. Taken together, these results suggest that Pbx1a and Klf4 interact, and that this interaction does not depend on DNA binding.
To test whether Klf4 could activate the p15 promoter, we expressed increasing amounts of Klf4 with or without Meis2d and Pbx1a. As shown in Figure 4D , we observed a small but significant increase in reporter activity with increasing Klf4 in the presence of Meis2d and Pbx1a, whereas there was no effect of Klf4 on basal activity. In contrast, coexpression of Sp1 or Sp3 did not increase activity (data not shown)To test whether Klf4 could bind to the endogenous p15 locus, we performed ChIP experiments using Flag-tagged Klf4 or Sp1, and analyzed recruitment to the p15 locus as before. We 
Pbx1 and Klf4 are recruited to the p15 and E-cadherin promoters
The E-cadherin gene has recently been shown to bind endogenous Klf4 in breast cancer cell lines (67) . We, therefore, tested whether modulation of Klf4 and Meis2 or Pbx1 levels affected p15 and E-cadherin expression in MCF7 cells. As shown in Figure 5A , siRNA-mediated knockdown of Pbx1 and Klf4 in these cells resulted in a clear reduction in both mRNA and protein levels, although effects of Meis2 knock-down in MCF7 had little effect (data not shown). As with our previous analysis in HepG2 cells we also observed a significant reduction in p15 and E-cadherin mRNA levels as with knock-down of either Pbx1 or Klf4 ( Figure 5B ). We next tested whether Pbx1 and Klf4 could be detected at the p15 and E-cadherin promoters in MCF7 cells, but this time analyzed binding of endogenous proteins. Chromatin was precipitated with antibodies against Pbx1 or Klf4, or with a IgG as a control, and the presence of the E-cadherin promoter and the -56 region of the p15 promoter analyzed by PCR. As shown in Figure 5C , Klf4 clearly bound to both the p15 and E-cadherin promoters, whereas it was not detected at the p15 3' region. We also observed binding of Pbx1 to both promoters, although this was somewhat harder to detect. Together, this data suggests that the endogenous Klf4-Pbx1 complex can bind to both p15 and E-cadherin promoters, and suggests that the cooperative regulation of gene expression by Klf4-Pbx1 complexes can occur in multiple cell types.
Identification of novel potential targets for Klf4-Meis/Pbx activation
We next created two mutant forms of the -967/+78 reporter, the first contained mutations in both of the GC boxes, and the second contained mutations in the M1 Meis site and the Pbx-like site (see Figure 3D) . Mutation of the GC boxes resulted in an increase in basal activity and a decrease in the response to coexpressed Meis2d and Pbx1a ( Figure   6A and C). In contrast, the mutations which disrupt the Meis-and Pbx-like sites (M/P on July 7, 2017 by guest http://mcb.asm.org/ Downloaded from mutant) had relatively little effect on activity either with or without co-expressed Meis2d and Pbx1a ( Figure 6A ). To examine whether the E-cadherin promoter responded similarly we made mutations in the GC box and an adjacent Pbx-like site. As shown in Figure 6B and C the E-cadherin reporter with a mutated GC box had lower basal activity, but a similar level of induction with Meis2 and Pbx1. However, unlike the p15 promoter, mutation of the Pbx site resulted in both lower activity and reduced induction by Meis2 and Pbx1 ( Figure 6B and C) . These data suggest that there is a variable requirement for Meis and Pbx sites in the p15 and E-cadherin promoters, and further suggest that the sequence requirements for cooperative activation by Meis/Pbx and Klf4 are quite variable, at least in terms of the Meis and Pbx binding sequences.
To further test the possibility that Meis/Pbx and Klf4 cooperatively activate gene expression we performed an in silico search for genes with conserved binding sites for all three proteins (http://www.sitesearch.mshri.on.ca/Genome/index.html; (59)). We were unable to search for degenerate Meis and Pbx sites since this would provide no selectivity, so we used the minimal five base consensus for each, combined with the sequence, RRGGYSY based on the Klf4 consensus. As outlined in Figure 6D , we restricted the search to the proximal 2kb upstream of the predicted transcriptional start site, and searched for a Klf4 site with both Meis and Pbx sites present within 40bp. This search yielded 484 hits with the combination of all three sites in the upstream region of the same gene in both mouse and human. To reduce this number we first took only those hits in which the sites were in the same order and same relative orientation to each other, in both species and ranked them by how similar the spacing between the sites was in mouse and human. By this ranking, the top 17 had exactly the same spacing between the three sites in both species, and the top 35 had only 6bp or less total difference (Supplemental Table 2 ). Of these top 35, published reporters were available for two of them. Pax3 has been shown to be regulated by Meis and Pbx, and a luciferase construct containing the potential Klf4-Meis/Pbx element was shown to respond to Meis2 and Pbx1 expression (11) . Although a luciferase reporter for Etv1 has been characterized, it had not been tested with either Meis/Pbx or Klf4 (8) . We obtained the reporters for Pax3 and Etv1 and tested them for cooperative activation by Klf4 and Meis/Pbx. The Pax3-luc reporter was clearly activated by coexpression of Meis2d and Pbx1a, whereas expression did not increase with Klf4 expression alone ( Figure 6E ).
Coexpression of all three proteins together resulted in a significant increase in activity over that seen with Meis2d and Pbx1a. With Etv1 we observed similar results, although Since the sequence requirements for binding of Meis2 and Pbx1 to a composite Klf4 element appear to be relatively relaxed, the identification of potential response elements is difficult. Our bioinformatic approach relied on the presence of a perfect match to the minimal 5bp consensus for both Meis2 and Pbx, since any further relaxation of the sequence provides too little selectivity. Most of the genes identified are not known to be Meis/Pbx responsive, with the exception of Pax3 (11) . However, we show that a Pax3 reporter responded cooperatively to Meis2d/Pbx1a and Klf4, suggesting that the search for composite elements was valid. Among the other top hits from this search, we were able to show cooperative activation by Meis2d/Pbx1a and Klf4 . mRNA was isolated after 60 hours, and was analyzed by qRT-PCR for expression of the indicated genes. Relative expression is shown as the average + s.d. of triplicates. Significance levels, as determined by Student's T test: * : p <0.05, ** : p <0.01, *** : p <0.001. C) ChIP was performed on chromatin from MCF7 cells using control IgG or antibodies to Pbx1 or Klf4. ChIP fractions were analyzed by PCR using primer sets to the E-cadherin promoter, the p15 proximal promoter (p15 -56) or as a negative control a 3' region of p15 (p15 3'). PCR on input chromatin is shown in the right lane. 
